Contents
Chapter I General Description of Veterinary Drug Industry 28
1.1 Definition and Classification of Veterinary drug 28
1.1.1 Definition of Drug for Veterinary use 28
1.1.2 Scope of Veterinary Drug 28
1.1.3 Definition and Classification of New Veterinary Drug, New Veterinary Drug Preparation and New Biological Preparation for Veterinary Use. 28
1.1.4 Definition of Medicament, Preparation and Prescription of Veterinary Drug and Dosage Form of Common Ceterinary Drug Preparation 30
1.2 General Situation of Development of Veterinary Drug 33
1.2.1 Brief History of Development of Traditional Chinese Veterinary Medicine 33
?1.2.2 Differences between Drugs for Veterinary and for Human Use 37
1.3. United Measurement Method for Veterinary Drugs 38
1.4 Analysis of the Environment of China’s Veterinary Drug Industry 39
1.4.1 Operation Situation of China’s Macro-economy in 2008 39
1.4.2 Analysis of Operation of China’s Economy at the First Quarter of 2009 45
1.4.3 Overall Development Trend of China’s Macro Economy in 2009 48
1.4.4 Revelation of Sanlu Scandal on Veterinary Drug Industry 54
1.5 Analysis of China’s Veterinary Drug Policies and Regulations 56
1.5.1 Basic Overview of North America’s Veterinary Drug Management System 56
1.5.2 Regulatory System of Veterinary Drugs Industry in China 60
1.5.3 Analysis of the Construction of Veterinary Drugs Management System in China 62
1.5.4 Main Policies and Regulations for Veterinary Drugs in China 69
1.5.5 Analysis on Standardization Process of Quality Standards of China’s Veterinary Drugs 72
1.5.6 Influence of Assorted Regulations of Animal Epidemic Prevention Law on veterinary drug industry 76
Chapter II Analysis of Status of China’s Veterinary Drug Industry in 2008 83
2.1 Development Status of China’s Veterinary Drug Industry 83
2.1.1 Basic Characteristics of Veterinary Drugs 83
2.1.2 Development Status of China’s Veterinary Drug Industry 84
2.1.3 China Will Facilitate Healthy Development of Veterinary Drug Industry 86
2.1.4 China Has Built 5 Non-Standard Animal Disease Demonstration Areas 87
2.1.5 The Largest Veterinary Drug Production in Northwest Area Conducted in Weinan 88
2.2 Analysis of Development of China’s Veterinary Drug Industry in 2008 89
2.2.1 Analysis of huge events of China’s veterinary drug industry in 2008 89
2.2.2 Random Quality Inspection of Veterinary Drug in 2008 90
2.3 Analysis of Problems Existing in China’s Veterinary Drug Production and Countermeasures 93
2.3.1 Analysis of Problems Existing in China’s Veterinary Drug Production 93
2.3.2 Analysis of Countermeasures of China’s Veterinary Drug Production 97
2.4.1 Problems in the Development of China’s Veterinary Drug Industry 99
2.4.2 Analysis of Cause of Problems in China’s Veterinary Drug Industry 100
2.4.3 Coping Strategy of the Development of China’s Veterinary Drug Industry 102
2.4.4 Proposals and Countermeasures of the Development of China’s Veterinary Drug Industry in 2009 106
Chapter III Development Analysis of China’s Veterinary Drug Market from 2008 to 2009 108
3.1 Development Situation of China’s Veterinary Drug Market from 2008 to 2009 108
3.1.1Market overview of various veterinary drugs in China in 2008 108
3.1.2 Analysis of China’s veterinary drug market in 2009 111
3.1.3 Demand Analysis of Veterinary Drug Market for Pigs in 2008 114
3.2 Analysis of the Circulation Market Behavior of China’s Veterinary Drugs 122
3.3 Analysis of Market Development of Chinese Veterinary Drugs 125
3.3.1 Development Advantages of Chinese veterinary drugs 125
3.3.2 Existing Problems on Development of Chinese Veterinary Drugs 126
3.3.3. Development Opportunity of Chinese Veterinary Drugs 129
3.3.4. Countermeasures on the development of Chinese veterinary drugs 130
3.4 Problems and countermeasures on the management of China’s veterinary drug market 131
3.4.1 Main Existing Problems on Veterinary Drug Market 131
3.4.2 Difficult points on the management of the veterinary market 133
3.4.3 Countermeasures on the market management of veterinary drugs 134
Chapter IV Analysis of Technological Research and Development in China’s Veterinary Drug Industry 136
4.1 Analysis of R& D Status in China’s Veterinary Drug Industry 136
4.1.1 Development Course of Research and Development of Veterinary Drugs 136
4.1.2 The Current Situation of Scientific Research in China’s Veterinary Drug Industry 139
4.1.3 Influencing Factors of Building Innovation Capacity of Veterinary Drugs in China 143
4.1.4 Analysis of Establishment of China’s Veterinary Drug R&D and Innovation Mechanism 147
4.2 Application of New Technologies in the R&D Production of Veterinary Drugs 152
4.2.1 The Current Status of New Technologies in the Research and Development of Veterinary Drugs 152
4.2.2 New Technologies of Extracting Veterinary Drugs 152
4.2.3 Separation and Purification Technologies of Veterinary Drugs 156
4.2.4 Other New Technologies of R&D and Production of Veterinary Drugs 159
4.3 Analysis of Research Progress of Chinese Veterinary Drug Preparation 161
4.3.1 Reserch Status Quo of Chinese Veterinary Drug Preparation 161
4.3.2 Six Advantages of Chinese Veterinary Drugs 165
4.3.3 Extract of Traditional Chinese Medicines Surges up New Technological Revolution of Veterinary Drugs 166
4.3.4 Problems Confronted with the Research on Chinese Veterinary Drug Preparation 169
4.3.5 Development Countermeasures of Chinese Veterinary Drug Preparation 170
4.4 Analysis of Research and Development of Chinese Veterinary Drugs and Feed Additive Made from Chinese Veterinary Drug 171
4.4.1 Natural Chinese Veterinary Drug and Feed Additive Made from Chinese Veterinary Drug 172
4.4.2 Research & Development and Application of Chinese Veterinary Drug and Feed Additive Made from Chinese Veterinary Drug 174
4.4.3 The Advantages of Combination of Chinese Veterinary Drug and Western Veterinary Drug 178
4.4.4 Development Direction of Research & Development on Preparation Forms of Chinese Veterinary Drugs and Compound Preparations of Chinese and Western Veterinary Drugs 181
4.5 Research and Development on Sustained-release Injectable Preparation for Animals 182
4.5.1 Preparation Forms of Sustained-release Injectable Preparations and Design Overview 182
4.5.2 The Current R&D Situations of Sustaibed-Release Injectable Preparations in China and in the World 186
4.5.3 Problems and Prospects of the Development of Injectable Sustained-Release Veterinary Preparations 190
4.6 Analysis of Development Problems and Countermeasures in the Veterinary Drug Industry of China 192
4.6.1 Main Problems in the Research and Development of Veterinary Drugs 192
4.6.2 Strategies for the R&D of Veterinary Drug in China 193
4.6.3 Countermeasures for the Research and Development of New Veterinary Drugs 194
4.7 Direction of the Research and Development of Chinese Veterinary Drugs 197
Chapter V Analysis of Performance of China Veterinary Drug Enterprises in 2008 200
5.1 Basic Performance of China Veterinary Drug Enterprises in 2008 200
5.1.1 General Performance of China Veterinary Drug Enterprises from 2007 to 2008 200
5.1.2 The General Operation of Veterinary Drug Industry from 2007 to 2008 208
5.1.3 The Assets and Liabilities Statement of Veterinary Drug Industry from 2007 to 2008 209
5.1.4 The Sales and Profits Statement of Veterinary Drug Industry from 2007 to 2008 211
5.1.5 Costs and Expenses Structure of China Veterinary Drug Industry from 2007 to 2008 213
5.2 Analysis of Solvency of China Veterinary Drug Industry from 2000 to 2008 215
5.3 Analysis of Profitability of China Veterinary Drug Industry from 2000 to 2008 218
5.4 Analysis of Operation of China Veterinary Drug Industry from 2003 to 2008 (by Scale) 221
5.4.1 Number of Veterinary Drug Enterprises by Different Scale in 2008 221
5.4.2 Total Assets of Veterinary Drug Enterprises by Different Scale in 2008 222
5.4.3 Sales Income of Veterinary Drug Enterprises by Different Scale in 2008 222
5.4.4 Profits of Veterinary Drug Enterprises by Different Scale in 2008 223
5.5 Analysis (by Enterprise Nature) of Operation of China Veterinary Drug Industry from 2003 to 2008 224
5.5.1 Number of Veterinary Drug Enterprises by Different Nature in 2008 224
5.5.2 Total Assets of Veterinary Drug Enterprises by Different Nature in 2008 225
5.5.3 Sales Income of Veterinary Drug Enterprises by Different Nature in 2008 226
5.5.4 Profits of Veterinary Drug Enterprises by Different Nature in 2008 227
5.6 Operation of China Veterinary Drug Industry by Region from 2007 to 2008 228
5.6.1 Assets and Liabilities of China Veterinary Drug Enterprises by Region from 2007 to 2008 230
5.6.2 Sales and Profits of China Veterinary Drug Enterprises by Region from 2007 to 2008 232
Chapter VI Analysis of Development of China’s Livestock and Poultry Market 234
6.1 Analysis of Development of China’s Breeding Industry in 2008 234
6.1.1 Status of domestic animal breeding of China in 2008 234
6.1.2 Analysis of China’s Livestock and Poultry Products in 2008 236
6.1.3 Status of Breeding Industry of Main Areas in China 238
6.1.4 Analysis of Pork Export, Import and Consumption in China in 2008 239
6.2 Analysis of Global Development of Animal Products 240
6.2.1 Overview of Global Livestock and Poultry Product from 2008 to 2009 240
6.2.2 Analysis of Global Pork Production and Export from 2008 to 2009 241
6.2.3 Analysis of Global Poultry Meat (Table Poultry) Production and Export 244
6.2.4 Analysis of Global Beef Production and Export from 2008 to 2009 247
6.3 Analysis of Development of China’s Livestock and Poultry Industry in 2008 248
6.3.1 Analysis of Development Status of poultry breeding industry in 2008 249
6.3.2 Analysis of Market Development Characteristics of China’s Poultry Industry in 2008 251
6.3.3 Analysis of Foreign Fund’s Entry into China’s Livestock and Poultry Industry 252
6.4 Analysis of Development of China’s Livestock and Poultry Clinics 255
6.5 Analysis of the Development of Chinese Livestock and Poultry Breeding Industry from 2008 to 2009 261
6.5.1 Analysis of the Development of China’s Chicken Breeding Industry from 2008 to 2009 261
6.5.2 Analysis of the Development of China’s Pig Industry from 2008 to 2009 268
6.5.3 Analysis of the Development of Chinese Aquatic Product Market from 2008 to 2009 275
Chapter VII Analysis of the Competition Pattern of Chinese Veterinary Drug Industry in 2008 280
7.1 Analysis of the Competition Environment of the Veterinary Drug Industry 280
7.1.1 Analysis of the Sales Environment of the Veterinary Drug Industry 280
7.1.2 The Impact of Standardization Breeding in the Marketing of Veterinary Drug 281
7.1.3 The Marketing Strategies in the Veterinary Drug Industry 283
7.2 Differentiated Marketing of Veterinary Drugs 286
7.2.1 Product Differentiation Is the Essence of the Differentiated Marketing 286
7.2.2 Price Differentiation is An Effective Tactic in Marketing 287
7.2.3 Channel Differentiation is A Result of Market Segmentation 289
7.2.4 Promotion Differentiation is Creative Marketing 289
7.3 Analysis on Technology Services Marketing 290
7.3.1 Analysis on Origins of Technology Service Marketing Mode 290
7.3.2 Analysis on Status Quo of Technology Service Marketing Mode 293
7.3.3 Analysis on Development and Evolution of Technology Services Marketing Mode 297
7.3.4 Technology Services Marketing Mode 301
7.4 Development and Marketing of Chinese Veterinary Drug Products 302
7.5 Analysis on Combined Marketing Strategy of Chinese Veterinary Drug Enterprises in 2008 307
7.5.1 Marketing Combination is A Basic Strategy of Veterinary Drug Enterprise 307
7.5.2 Marketing Combination Is the Driving Force of Veterinary Drug Entrprises 308
7.5.3 Status Quo of Marketing Mix of Veterinary Drug Industry 313
7.6 Strategic Analysis on Chinese Animal Health Industry in 2008 314
Chapter VIII Analysis on Veterinary Drug Market of Main Regions in China 324
8.1 Analysis on Development of Veterinary Drug Industry in Jiangsu 324
8.1.1 Production Status Quo of Veterinary Drug Industry in Jiangsu 324
8.1.2 Analysis on the Operation of Veterinary Drug Industry in Jiangsu 329
8.1.3 Analysis on the Management of Veterinary Drug Industry in Jiangsu 332
8.1.4 Analysis on New Veterinary Drug Development in Jiangsu 339
8.1.5 Veterinary Drug Residue Control in Jiangsu Province 340
8.2 Development Status Quto of Veterinary Drug Industry in Shandong Province 342
8.2.1 Economic Operating Status of Veterinary Drug Industry in Shandong Province 342
8.2.2 Analysis on the Development of Veterinary Drug Industry in Shandong Province during the Tenth Five-Year 344
8.2.3 Quality Problems of Veterinary Drugs in Shandong Province 348
8.3 Development Analysis on Veterinary Drug Industry in Hubei Province 353
8.3.1 Status Quo of Veterinary Drug Industry in Hubei Province 353
8.3.2 Problems Existing in the Development of Veterinary Drug Industry in Hubei Province 354
8.3.2 Solutions to the Development of Veterinary Drug Industry in Hubei Province 355
8.4 Development Status of Veterinary Drug Industry in Gansu Province 358
8.4.1 R&D Status of Veterinary Drug Industry in Gansu Province 358
8.4.2 Factors Limiting the Development of Veterinary Drug Industry in Gansu Province 359
8.4.3 Keys and Targets of the Research of veterinary Drug Industry in Gansu Province 360
8.5 Analysis on Investigations of GMP Certification in Veterinary Drug Enterprises in Sichuan Province 362
8.5.1 Overview of Veterinary Drug GMP Certification Situation in Sichuan Province 362
8.5.2 Status Quo of the Development of Veterinary Drug Industry in Sichuan Province 364
8.5.3 Solutions of Veterinary Drug Industry in Sichuan Province to the GMP certification 370
8.6 Analysis of the Development of Veterinary Drug Industry in Other Regions 373
8.6.1 Analysis of the Development of the Chineses Veterinary Drug Industry in Guangxi 373
8.6.2 Analysis of Rapid Development of Veterinary Drug Enterprises in Henan Province 379
Chapter IX Competitive Analysis of Chinese Enterprises of Veterinary Drugs 382
9.1 Analysis of Developing Strategy for Chinese Enterprises of Veterinary Drugs 382
9.1.1 Significance of Establishing Developing Strategy by Enterprises of Veterinary Drugs 382
9.1.2 Strategy Choice of Chinese Enterprises of Venerinary Drugs 383
9.1.3 Main Policies for Becoming Bigger and Stronger of Chinese Enterprises of Veterinary Drugs 384
9.1.4 Analysis on the Price War in Enterprises of Veterinary Drugs 388
9.2 Analysis on Developing Strategy of Enterprises of Veterinary Drugs 390
9.2.1 Developing Strategy of Enterprises of Veterinary Drugs in 2008 390
9.2.2 Terminal Promotion of Veterinary Drugs 394
9.2.3 Regional Marketing Strategy of Veterinary Drugs 395
9.3 Thinking and Strategy of Dealers of Veterinary Drugs 400
9.3.1 Analysis on Environment of Dealers of Veterinary Drugs 400
9.3.2 Analysis on Crises of Distribution of Veterinary Drugs 403
9.3.3 Analysis on Thinking of Distribution of Veterinary Drugs 404
9.3.4 Analysis on Distribution Strategy of Veterinary Drugs 407
9.4 Advantages of Cultivating Veterinary Drug Enterprise 411
9.4.1 Veterinary Drug Enterprise Developing Needs Marketing Innovation 411
9.4.2 Adjustment of Research and Development of Veterinary Drug Enterprises under New Situation 413
9.4.3 Brand Operation of Veterinary Drugs 414
9.4.4 Analysis of Veterinary Drug Enterprise’s Cut-throat Competition 416
9.5 Competitive Analysis of Small and Medium-sized Veterinary Drug Enterprise 419
9.5.1 How to Counter the Bottleneck for the Development of Veterinary Drug Enterprise 419
9.5.2 Direction of Small and Medium-sized Veterinary Drug Enterprise’s Product Development 424
9.6 Market Analysis of Veterinary Drugs in the New Era and Training of New Dealers 427
9.6.1 Initial Projection of Veterinary Drug Industry in the Era of Post-GMP 427
9.6.2 Trend Pattern of Veterinary Drug Industry in the Era of Post- GMP 428
9.6.3 Impact on Veterinary Drug Dealers Caused by Industry Change 429
9.6.4 Analysis at This Stage the Situation of Veterinary Drug Dealers 431
9.6.5 New Road of Distributor Refinery 431
Chapter X GMP and GSP Aanalysis of Veterinary Drug Industry in China 433
10.1 GMP Summary of Veterinary Drug Industry 433
10.1.1 GMP Concept of Veterinary Drug Industry 433
10.1.2 Historical Background and Development Overview of GMP 433
10.1.3 The Purpose and Significane of Implementing Veterinary Drugs GMP 436
10.1.4 Analysis of Each Implementation Stage of GSP 440
10.2 Current GMP Situation of Veterinary Drug Enterprises 443
10.2.1 GMP Implementation Progress of Veterinary Drug Enterprises in China 443
10.2.2 Problems Existing in the Course Veterinary Drugs GMP Authentication 444
10.2.3 Suggestions in the Course of Veterinary Drugs GMP Authentication 446
10.3 Analysis of Veterinary Drug Industry in post-GMP Era 448
10.3.1 Service Analysis of Veterinary Drug Industry in post-GMP Era 448
10.3.2 Development Strategies of Veterinary drug Enterprises in post-GMP Era 455
10.4 Basic Situation of Development of GSP 464
10.4.1 Brief Introduction of GSP 464
10.4.2 Pilot Situation of Veterinary Drug GSP in China in 2008 464
10.4.3 Impact of GSP on Chinese Veterinary Drug Production and Circulation Field 468
10.4.4 Experience and Advantages of Veterinary Drug GSP Chain-Store Operation 474
10.5 Development Prospect and Trend of Veterinary Drug GSP 476
10.5.1 Development Prospect of Veterinary Drug GSP 476
10.5.2 Consideration of Enforced Implement of GSP (Good Supplying Practice) in 2009 480
Chapter XI Analysis of Performance of China Main Veterinary Drug Enterprises in 2008 483
11.1 Rankings of China Veterinary Drug Enterprises from 2007 to 2008 483
11.2 Hebei Veyong Biochemical Co.,Ltd. 485
11.2.1 Basic Information 485
11.2.2 Performance in 2008 486
11.2.3 Financial Status from 2003 to 2009 488
11.2.4 Future Development Strategy 491
11.2.5 Analysis of Risks and Countermeasures 492
11.3 Zhejiang Qianjiang Biochemical Co.,Ltd. 493
11.3.1 Enterprise Basic Situation 493
11.3.2 The Enterprise Performance in 2008 494
11.3.3 Enterprise Financial Statement from 2003 to 2009 498
11.3.4 Enterprise’s Future Development Strategy 501
11.3.5 Analysis of Risks and Coutermeasures 502
11.4 China Animal Husbandry Industry Co., Ltd. 502
11.4.1 Enterprise Basic Situation 503
11.4.2 Business Conditions of Enterprises in 2008 507
11.4.3 Finance Conditions of Enterprises from 2003 to 2009 509
11.4.4 Future Developing Strategy of Enterprise 512
11.4.5 Analysis of the Risk and Strategy of Enterprises 513
11.5 Xinjiang Tiankang Husbandary Biotechnology Co., Ltd. 513
11.5.1 Company Profile 513
11.5.2 Company Performance in 2008 516
11.5.3 Financial Standing from 2003 to 2009 517
11.5.4 Future Development Strategy 517
11.5.5 Risks and Countermeasures 521
11.6 Xinchang Guobang Chemical Industry Co., Ltd. 522
11.6.1 Enterprise Basic Situation 522
11.6.2. Analysis of enterprise solvency 524
11.6.3. Analysis of the Profitability of the Business 525
11.6.4. Analysis of Enterprise Cost 526
11.7 JiangSu TianCheng Health Product Co., Ltd 527
11.7.1 Enterprise Basic Situation 527
11.7.2 Analysis of Enterprise Solvency 529
11.7.3 Analysis of the Profitability of the Business 529
11.7.4 Analysis of Enterprise Cost 531
11.8 Jinan Guta Veterinary Drug Co., Ltd. 532
11.8.2 Analysis of Enterprise Solvency 534
11.8.3 Analysis of the Profitability of the Business 534
11.8.4 Analysis of Enterprise Cost 535
11.9 Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences 537
11.9.1 Enterprise Basic Situation 537
11.9.2 Analysis of Enterprise Solvency 538
11.9.3 Analysis of the Profitability of the Business 538
11.9.4 Analysis of Enterprise Cost 540
11.10 Shandong Qifa Pharmaceutical Co., Ltd. 540
11.10.1 Enterprise Basic Situation 540
11.10.2 Analysis of Enterprise Solvency 541
11.10.3 Analysis of the Profitability of the Business 542
11.10.4 Analysis of Enterprise Cost 543
11.11 Ningxia Duoweitairui Pharmaceutical Co., Ltd. 544
11.11.1 Enterprise Basic Situation 544
11.11.2 Analysis of Enterprise Solvency 545
11.11.3 Analysis of the Profitability of the Business 546
11.11.4 Analysis of Enterprise Cost 547
11.12 Qingdao Yebio Bioengineering Co., Ltd. 549
11.12.1 Enterprise Basic Situation 549
11.12.2 Analysis of Enterprise Solvency 550
11.12.3 Analysis of the Profitability of the Business 551
11.12.4 Analysis of Enterprise Cost 552
11.13 Zhejiang Guobang Pharmaceutical Co., Ltd. 553
11.13.1 Enterprise Basic Situation 553
11.13.2 Analysis of enterprise solvency 554
11.13.3 Analysis of the Profitability of the Business 555
11.13.4 Analysis of Enterprise Cost 556
11.14 Shandong Xinfa Pharmaceutical Co., Ltd. 557
11.14.1 Enterprise basic situation 557
11.14.2 Analysis of enterprise solvency 558
11.14.3 Analysis of the profitability of the business 559
11.14.4 Analysis of Enterprise Cost 560
11.15 Chongqing Sanxia Livestocks Industry Group Co., Ltd. 561
11.15.1 Enterprise basic situation 561
11.15.2 Analysis of enterprise solvency 562
11.15.3 Analysis of the profitability of the business 563
11.15.4 Analysis of enterprise cost 563
11.16 Harbin Weike Biotechnology Development Co., Ltd. 564
11.16.1 Enterprise basic situation 564
11.16.2 Analysis of enterprise solvency 566
11.16.3 Analysis of the Profitability of the Business 567
11.16.4 Analysis of Enterprise Cost 567
11.17 Jinyu Baoling Bio-pharmaceutical Co., Ltd. 568
11.17.1 Enterprise Basic Situation 568
11.17.2 Analysis of enterprise solvency 570
11.17.3 Analysis of the Profitability of the Business 571
11.17.4 Analysis of Enterprise Cost 571
11.18 Guangdong Tengjun Animal Pharmaceutical Co., Ltd. 572
11.18.1 Enterprise basic situation 572
11.18.2 Analysis of enterprise solvency 574
11.18.3 Analysis of the Profitability of the Business 575
11.18.4 Analysis of Enterprise Cost 575
Chapter XII Development Prospect and Trend of Veterinary Drug Industry in China 577
12.1 Developmetn Prospect of Veterinary Drug Industry 577
12.1.1 Development Prospect of Veterinary Drug Industry in China 577
12.1.2 Market Prospect of Veterinary Drugs in 2009 578
12.1.3 Attention for Veterinary Drug Industry of China in 2009 582
12.2 Analysis on Development Trend of Veterinary Drug Industry 585
12.2.1. Development Trend of Chinese Veterinary Drug Industry in 2009 585
12.2.2. Future Devolopment Trend of Veterinary Drug Industry in China 587
12.2.3. Sales Revenue Forecast of Chinese Veterinary Industry from 2009 to 2013 589
12.2.4 Main Trends of Future Veterinary Drug’s Variety 590
Attachment: Report Instruction 592
Figure Contents
Figure 1 China’s GDP growth trend chart from 2004 to 2008 39
Figure 2 Sales price rise and fall range of China’s residents from 2004 to 2008 40
Figure 3 Year-on-year rise and drop range of consumer price of Chinese resident in 2008 40
Figure 4 China’s foreign exchange reserves from 2004 to the end of 2008 41
Figure 5 China’s tax revenue and growth rate from 2004 to 2008 41
Figure 6 Per capital net income and its growth rate of China’s rural residents from 2004 to 2008 42
Figure 7 Per capital net income and its growth rate of China’s urban residents from 2004 to 2008 42
Figure 8 Overall retail sales of China’s social consumer and its growth rate from 2004 to 2008 43
Figure 9 China’s grain output and its growth rate from 2004 to 2008 44
Figure 10 Chinese population and the structure thereof in 2008 45
Figure 11 Prediction on key economic indicators of China in 2009 49
Figure 12 Summary statement of spot check on veterinary drugs evaluation in the 4th quarter of 2008 91
Figure 13 List of enterprises key supervised and controlled by Ministry of Agriculture in 2008 91
Figure 14 List of Chinese Illegal Veterinary Drugs Manufacturers in 2008 92
Figure 15 The market structure of China’s veterinary drugs in 2008 109
Figure 16 Purchase cost structure of veterinary drugs pie chart of China’s chicken breeding companies in 2008 109
Figure 17 Purchase cost structure of veterinary drugs pie chart of China’s chicken breeding companies in 2008 110
Figure 18 Statistics of dosage form amount of Chinese veterinary drugs enterprises 140
Figure 19 Injectable Sustained-Release Preparation Products for Veterinary Use to be Listed Abroad at Present 187
Figure 20 Economic indicators statistics of veterinary drug industry of China in 2007 200
Figure 21 Rank of number of enterprises in the top five provinces of veterinary drug industry in 2007 202
Figure 22 Rank of gross industrial output value in the top five provinces of veterinary drug industry in 2007 203
Figure 23 Rank of total assets in the top five provinces of veterinary drug industry in 2007 203
Figure 24 Rank of sales income in the top five provinces of veterinary drug industry in 2007 203
Figure 25 Rank of total profits in the top five provinces of veterinary drug industry in 2007 204
Figure 26 Economic indicators statistics of veterinary drug industry of China in 2007 204
Figure 27 Rank of number of enterprises in the top five provinces of veterinary drug industry in 2008 206
Figure 28 Rank of gross industrial output value in the top five provinces of veterinary drug industry in 2008 207
Figure 29 Rank of total assets in the top five provinces of veterinary drug industry in 2008 207
Figure 30 Rank of sales income in the top five provinces of veterinary drug industry in 2008 207
Figure 31 Rank of total profits in the top five provinces of veterinary drug industry in 2008 208
Figure 32 Changes in the number of China veterinary drug enterprises from 2001 to 2008 208
Figure 33 Change of employees in veterinary drugs enterprises of China from 2000 to 2008 209
Figure 34 Statistics and growth rate of assets of veterinary drug industry of China from 2000 to 2008 209
Figure 35 Assets increase trend of China veterinary drug industry from 2000 to 2008 210
Figure 36 Statistics and growth rate of current assets of veterinary drug industry of China from 2000 to 2008 210
Figure 37 Statistics and growth rate of fixed assets of veterinary drug industry of China from 2000 to 2008 210
Figure 38 Statistics and growth rate of liabilities of veterinary drug industry of China from 2000 to 2008 211
Figure 39 Statistics and growth rate of sales volume of veterinary drug industry of China from 2000 to 2008 211
Figure 40 Sales increase trend chart of China veterinary drug industry from 2000 to 2008 212
Figure 41 Statistics and growth rate of total profits of veterinary drug industry of China from 2000 to 2008 212
Figure 42 Profits increase trend chart of China veterinary drug industry from 2000 to 2008 213
Figure 43 Costs and expenses structure of China veterinary drug industry in 2008 213
Figure 44 Statistics and growth rate of sales costs of veterinary drug industry of China from 2000 to 2008 213
Figure 45 Statistics and growth rate of sales expenses of veterinary drug industry of China from 2000 to 2008 214
Figure 46 Statistics and growth rate of management expenses of veterinary drug industry of China from 2000 to 2008 214
Figure 47 Statistics and growth rate of financial expenses of veterinary drug industry of China from 2000 to 2008 215
Figure 48 Solvency change in veterinary drugs industry of China from 2000 to 2008 216
Figure 49 Solvency comparison of China veterinary drug industry in 2008 216
Figure 50 Solvency comparison of China veterinary drug industry in 2007 217
Figure 51 Ratio of profits to costs of veterinary drug industry of China from 2000 to 2008 218
Figure 52 Gross profit of veterinary drug industry of China from 2000 to 2008 218
Figure 53 Ratio of sales profits of veterinary drug industry of China from 2000 to 2008 219
Figure 54 Comparison of profitability in veterinary drugs industry of China in 2008 219
Figure 55 Comparison of profitability in veterinary drugs industry of China in 2008 220
Figure 56 Statistics of the number of veterinary drugs enterprises of China in different scale from 2003 to 2008 221
Figure 57 Statistics of the number of employees of veterinary drugs industry of China in different scale from 2003 to 2008 221
Figure 58 Total assets of veterinary drugs enterprises of China in different scale from 2003 to 2008 222
Figure 59 Total liabilities of veterinary drugs enterprises of China in different scale from 2003 to 2008 222
Figure 60 Sales income statistics of veterinary drugs enterprises of China in different scale from 2003 to 2008 223
Figure 61 Market share proportion chart of veterinary drug enterprises by different scale in 2008 223
Figure 62 Total profits of veterinary drugs enterprises of China in different scale from 2003 to 2008 223
Figure 63 Profits share proportion chart of veterinary drug enterprises by different scale in 2008 224
Figure 64 Statistics of the number of veterinary drugs enterprises of China in different nature from 2003 to 2008 224
Figure 65 Statistics of the number of employees of veterinary drugs enterprises of China in different nature from 2003 to 2008 225
Figure 66 Total assets of veterinary drugs industry of China in different nature from 2003 to 2008 225
Figure 67 Total liabilities of veterinary drugs enterprises of China in different nature from 2003 to 2008 226
Figure 68 Statistics of sales income of veterinary drugs enterprises of China in different nature from 2003 to 2008 227
Figure 69 Market share comparison chart of veterinary drug enterprises by different nature in 2008 227
Figure 70 Statistics of total profits of veterinary drugs enterprises of China in different nature from 2003 to 2008 228
Figure 71 Profits proportion comparison chart of veterinary drug enterprises by different nature in 2008 228
Figure 72 Comparison of the number of veterinary drugs enterprises in different regions of China from 2007 to 2008 229
Figure 73 Comparison of the output value of veterinary drugs enterprises in different regions of China from 2007 to 2008 230
Figure 74 Comparison of the assets of veterinary drugs enterprises in different regions of China from 2007 to 2008 231
Figure 75 Liabilities comparison of veterinary drug enterprises by different region from 2007 to 2008 232
Figure 76 Comparison of the sales volume of veterinary drugs enterprises in different regions of China from 2007 to 2008 233
Figure 77 Comparison of the profits of veterinary drugs enterprises in different regions of China from 2007 to 2008 234
Figure 78 Statistics of the number of main raised livestock from 2002 to 2008 235
Figure 79 Statistics of the output of main livestock and poultry products from 2002 to 2008 236
Figure 80 Growth trend chart of meat in China from 2001 to 2008 237
Figure 81 Growth trend chart of pork in China from 1996 to 2008 237
Figure 82 Growth trend chart of beef in China from 1996 to 2008 238
Figure 83 Growth trend chart of mutton in China from 1996 to 2008 238
Figure 84 Development of livestock-raising industry in different regions of China in 2007 238
Figure 85 Pork products consumption and imports and exports of China from 1996 to 2007 240
Figure 86 Prediction of global livestock and poultry meat import demand from 2003 to 2009 241
Figure 87 Statistics of global pork production from 1998 to 2009 242
Figure 88 Pork export status of main countries in the world from 1998 to 2009 243
Figure 89 Production and consumption of pork in main countries all over the world from 2004 to 2009 243
Figure 90 Statistics of pork production allocation in main countries all over the world from 2004 to 2009 244
Figure 91 Outputs of main table poultry production countries from 1998 to 2009 245
Figure 92 Export status of main table poultry export countries from 1998 to 2009 246
Figure 93 Status of global beef production from 2004 to 2009 247
Figure 94 Production and consumption of beef in main country all over the world from 2004 to 2009 248
Figure 95 The import volume of parent-generation laying hens in China from 2005 to 2008 261
Figure 96 The species structure of laying hens in China in 2008 261
Figure 97 Boston matrix product analysis model 309
Figure 98 Operation of veterinary drugs industry in Jiangsu from 2007 to 2008 328
Figure 99 Economic benefit indicator status of veterinary drugs industry in Jiangsu from 2007 to 2008 329
Figure 100 Operation of veterinary drugs industry in Shandong from 2007 to 2008 343
Figure 101 Economic benefit indicator status of veterinary drugs industry in Shandong from 2007 to 2008 343
Figure 102 The employee educational background allocation of veterinary drugs enterprises in Sichuan 363
Figure 103 The employee professional title allocation of veterinary drugs enterprises in Sichuan 364
Figure 104 Analysis of the strategy of market positioning 386
Figure 105 Concentration of veterinary drugs industry of China 483
Figure 106 Top ten veterinary drugs enterprises in sales volume in 2007 483
Figure 107 Top ten veterinary drugs enterprises in output value in 2007 484
Figure 108 Top ten veterinary drugs enterprises in profits in 2007 484
Figure 109 Top ten veterinary drugs enterprises in assets in 2007 485
Figure 110 Main business in different industries of Xinjiang Tiankang Animal Biotechnology Co., Ltd in 2008 487
Figure 111 Main business in different regions of Xinjiang Tiankang Animal Biotechnology Co., Ltd in 2008 487
Figure 112 Statistics of assets and liabilities of Hebei Weiyuan Biochemical Co., Ltd. from 2003 to 2009 488
Figure 113 Statistics of sales and profits of Hebei Weiyuan Biochemical Co., Ltd. from 2003 to 2009 488
Figure 114 Statistics of costs and expenses of Hebei Weiyuan Biochemical Co., Ltd. from 2003 to 2009 489
Figure 115 Solvency of Hebei Weiyuan Biochemical Co., Ltd. from 2003 to 2009 489
Figure 116 Statistics of operating efficiency of Hebei Weiyuan Biochemical Co., Ltd. from 2003 to 2009 490
Figure 117 Statistics of profitability of Hebei Weiyuan Biochemical Co., Ltd. from 2003 to 2009 490
Figure 118 Statistics of growth capacity of Hebei Weiyuan Biochemical Co., Ltd. from 2003 to 2009 490
Figure 119 Employees in different professional composition of Zhejiang Qianjiang Biochemical Co., Ltd. 494
Figure 120 Employees in different educational background of Zhejiang Qianjiang Biochemical Co., Ltd. 494
Figure 121 Main business in different industries of Zhejiang Qianjiang Biochemical Co., Ltd. in 2008 495
Figure 122 Main business in different products of Zhejiang Qianjiang Biochemical Co., Ltd. in 2008 496
Figure 123 Main business in different regions of Zhejiang Qianjiang Biochemical Co., Ltd. in 2008 496
Figure 125 Statistics of assets and liabilities of Zhejiang Qianjiang Biochemical Co., Ltd from 2003 to 2009 498
Figure 126 The sales and profits of Zhejiang Qianjiang Biochemical Co., Ltd from 2003 to 2009 498
Figure 127 Statistics of costs and expenses of Zhejiang Qianjiang Biochemical Co., Ltd from 2003 to 2009 499
Figure 128 The solvency of Zhejiang Qianjiang Biochemical Co., Ltd from 2003 to 2009 499
Figure 129 Statistics of operating efficiency of Zhejiang Qianjiang Biochemical Co., Ltd. from 2003 to 2009 499
Figure 130 Profitability of Zhejiang Qianjiang Biochemical Co., Ltd from 2003 to 2009 500
Figure 131 Growth capacity of Zhejiang Qianjiang Biochemical Co., Ltd from 2003 to 2009 500
Figure 132 Operation planning of Zhejiang Qianjiang Biochemical Co., Ltd in 2009 501
Figure 133 Number of employees in different professions of Zhongmu Industrial Co., Ltd 506
Figure 134 Number of employees in different educational background of Zhongmu Industrial Co., Ltd 506
Figure 135 Completion status of main business indicator of China Animal Husbandry Industry Co., Ltd. in 2008 507
Figure 137 Statistics of assets and liabilities of China Animal Husbandry Industry Co., Ltd. from 2003 to 2009 509
Figure 138 Statistics of sales and profits of China Animal Husbandry Industry Co., Ltd. from 2003 to 2009 510
Figure 139 Statistics of costs and expenses of China Animal Husbandry Industry Co., Ltd. from 2003 to 2009 510
Figure 140 Solvency of China Animal Husbandry Industry Co., Ltd. from 2003 to 2009 510
Figure 141 Statistics of operating efficiency of China Animal Husbandry Industry Co., Ltd. from 2003 to 2009 511
Figure 142 Statistics of profitability of China Animal Husbandry Industry Co., Ltd. from 2003 to 2009 511
Figure 143 Statistics of growth capacity of China Animal Husbandry Industry Co., Ltd. from 2003 to 2009 511
Figure 155 Financial indicator plan of Xinjiang Tiankang Animal Biotechnology Co., Ltd. in 2009 518
Figure 156 Sale objective planning of product sales of Xinjiang Tiankang Animal Biotechnology Co., Ltd. in 2009 519
Figure 157 Statistics of assets of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 524
Figure 158 Statistics of liabilities of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 524
Figure 159 Assets liabilities ratio of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 524
Figure 160 Statistics of sales of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 525
Figure 161 Statistics of profits of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 525
Figure 162 Ratio of profits to cost of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 525
Figure 163 Gross profit to sales ratio of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 525
Figure 164 Ratio of profits to sales of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 526
Figure 165 Asset profit rate of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 526
Figure 166 Cost structure of Xinchang Guobang Chemical Industry Co., Ltd. in 2007 526
Figure 167 Statistics of sales costs of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 526
Figure 168 Statistics of sales expenses of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 526
Figure 169 Statistics of management expenses of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 527
Figure 170 Statistics of financial expenses of Xinchang Guobang Chemical Industry Co., Ltd. from 2004 to 2007 527
Figure 171 Statistics of assets of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 529
Figure 172 Statistics of liabilities of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 529
Figure 173 Assets liabilities ratio of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 529
Figure 174 Statistics of sales of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 530
Figure 175 Statistics of profits of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 530
Figure 176 Ratio of profits to cost of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 530
Figure 177 Gross profit to sales ratio of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 530
Figure 178 Profit to sales ratio of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 530
Figure 179 Rate of return on assets of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 531
Figure 180 Cost Structure of JiangSu TianCheng Health Product Co., Ltd in 2007 531
Figure 181 Statistics of sales costs of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 531
Figure 182 Statistics of sales expenses of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 531
Figure 183 Statistics of management expenses of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 532
Figure 184 Statistics of financial expenses of JiangSu TianCheng Health Product Co., Ltd from 2003 to 2007 532
Figure 185 Statistics of assets of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 534
Figure 186 Statistics of liabilities of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 534
Figure 187 Assets liabilities ratio of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 534
Figure 188 Statistics of sales of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 534
Figure 189 Statistics of profits of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 535
Figure 190 Ratio of profits to cost of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 535
Figure 191 Gross profits to sales ratio of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 535
Figure 192 Ratio of profits to sales of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 535
Figure 193 Asset profits ratio of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 535
Figure 194 Cost Structure of Jinan Guta Veterinary Drug Co., Ltd. in 2007 536
Figure 195 Statistics of selling costs of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 536
Figure 196 Statistics of sales expenses of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 536
Figure 197 Statistics of management expenses of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 536
Figure 198 Statistics of financial expenses of Jinan Guta Veterinary Drug Co., Ltd. from 2003 to 2007 536
Figure 199 Statistics of assets of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 538
Figure 200 Statistics of liabilities of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 538
Figure 201 Assets liabilities ratio of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 538
Figure 202 Statistics of sales of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 539
Figure 203 Statistics of profits of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 539
Figure 204 Ratio of profits to costs of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 539
Figure 205 Gross profits to sales ratio of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 539
Figure 206 Ratio of profits to sales of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 539
Figure 207 Rate of return on assets of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 539
Figure 208 Statistics of sales costs of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 540
Figure 209 Statistics of sales expenses of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 540
Figure 210 Statistics of management expenses of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 540
Figure 211 Statistics of financial expenses of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences from 2003 to 2007 540
Figure 212 Statistics of assets of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 541
Figure 213 Statistics of liabilities of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 542
Figure 214 Assets liabilities ratio of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 542
Figure 215 Statistics of sales of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 542
Figure 216 Statistics of profits of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 542
Figure 217 Ratio of profits to costs of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 542
Figure 218 Gross profit to sales ratio of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 543
Figure 219 Ratio of profits to sales of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 543
Figure 220 Rate of return on assets of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 543
Figure 221 Cost Structure of Shandong Qifa Pharmaceutical Co., Ltd. in 2007 543
Figure 222 Statistics of sales costs of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 543
Figure 223 Statistics of sales expenses of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 544
Figure 224 Statistics of management expenses of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 544
Figure 225 Statistics of financial expenses of Shandong Qifa Pharmaceutical Co., Ltd. from 2004 to 2007 544
Figure 226 , Statistics of Assets of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 546
Figure 227 Statistics of Liabilities of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 546
Figure 228 Assets liabilities Ratio of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 546
Figure 229 Statistics of Sales of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 546
Figure 230 Statistics of Profits of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 547
Figure 231 Ratio of Profits to Costs of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 547
Figure 232 Gross profit to sales ratio of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 547
Figure 233 Ratio of profits to sales of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 547
Figure 234 Rate of return on assets of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 547
Figure 235 Structure of Costs Expenses of Ningxia Duoweitairui Pharmaceutical Co., Ltd. in 2007 548
Figure 236 Statistics of Sales Costs of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 548
Figure 237 Statistics of Sales Expenses of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 548
Figure 238 Statistics of Management Expenses of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007s 548
Figure 239 Statistics of Financial Expenses of Ningxia Duoweitairui Pharmaceutical Co., Ltd. from 2003 to 2007 548
Figure 240 Balance Sheet of Qingdao Yebio Bioengineering Co., Ltd. from 2007 to 2008 550
Figure 241 Solvency of Qingdao Yebio Bioengineering Co., Ltd. from 2007 to 2008 551
Figure 242 Sales and profits statement of Qingdao Yebio Bioengineering Co., Ltd. from 2007 to 2008 551
Figure 243 Profitability of Qingdao Yebio Bioengineering Co., Ltd. from 2007 to 2008 552
Figure 244 Structural Chart of Costs Expenses of Qingdao Yebio Bioengineering Co., Ltd. from 2007 to 2008 552
Figure 245 Statistics of Costs and Expenses of Qingdao Yebio Bioengineering Co., Ltd. from 2007 to 2008 552
Figure 246 Balance sheet of Zhejiang Guobang Pharmaceutical Co., Ltd. from 2007 to 2008 554
Figure 247 Solvency of Zhejiang Guobang Pharmaceutical Co., Ltd. from 2007 to 2008 555
Figure 248 Sales and profits statement of Zhejiang Guobang Pharmaceutical Co., Ltd. from 2007 to 2008 555
Figure 249 Profitability of Zhejiang Guobang Pharmaceutical Co., Ltd. from 2007 to 2008 555
Figure 250 Cost structural drawing of Zhejiang Guobang Pharmaceutical Co., Ltd for the Year 2007-2008 556
Figure 251 Statistics of costs and expenses of Zhejiang Guobang Pharmaceutical Co., Ltd. from 2007 to 2008 556
Figure 252 Balance sheet of Shandong Xinfa Pharmaceutical Co., Ltd. from 2007 to 2008 558
Figure 253 Debt paying ability of Shandong Xinfa Pharmaceutical Co., Ltd. from 2007 to 2008 559
Figure 254 Sales and profits statement of Shandong Xinfa Pharmaceutical Co., Ltd. from 2007 to 2008 559
Figure 255 Profitability of Shandong Xinfa Pharmaceutical Co., Ltd. from 2007 to 2008 559
Figure 256 Cost structural drawing of Shandong Xinfa Pharmaceutical Co., Ltd for the Year 2007-2008 560
Figure 257 Statistics of costs and expenses of Shandong Xinfa Pharmaceutical Co., Ltd. from 2007 to 2008 560
Figure 258 Balance sheet of Chongqing Sanxia Livestocks Industry Group Co., Ltd. from 2007 to 2008 562
Figure 259 Solvency of Chongqing Sanxia Livestocks Industry Group Co., Ltd. from 2007 to 2008 562
Figure 260 Sales and profits statement of Chongqing Sanxia Livestocks Industry Group Co., Ltd. from 2007 to 2008 563
Figure 261 Profitability of Chongqing Sanxia Livestocks Industry Group Co., Ltd. from 2007 to 2008 563
Figure 262 Cost structural drawing of Chongqing Sanxia Livestocks Industry Group Co., Ltd for the Year 2007-2008 563
Figure 263 Statistics of costs and expenses of Chongqing Sanxia Livestocks Industry Group Co., Ltd. from 2007 to 2008 564
Figure 264 Balance sheet of Harbin Weike Biotechnology Development Co., Ltd. from 2007 to 2008 566
Figure 265 Solvency of Harbin Weike Biotechnology Development Co., Ltd. from 2007 to 2008 567
Figure 266 Sales and profits statement of Harbin Weike Biotechnology Development Co., Ltd. from 2007 to 2008 567
Figure 267 Profitability of Harbin Weike Biotechnology Development Co., Ltd. from 2007 to 2008 567
Figure 268 Cost structural drawing of Harbin Weike Biotechnology Development Co., Ltd for the Year 2007-2008 567
Figure 269 Statistics of costs and expenses of Harbin Weike Biotechnology Development Co., Ltd. from 2007 to 2008 568
Figure 270 Balance sheet of Jinyu Baoling Bio-pharmaceutical Co., Ltd. from 2007 to 2008 570
Figure 271 Debt paying ability of Jinyu Baoling Bio-pharmaceutical Co., Ltd. from 2007 to 2008 571
Figure 272 Sales and profits statement of Jinyu Baoling Bio-pharmaceutical Co., Ltd. from 2007 to 2008 571
Figure 273 Profitability of Jinyu Baoling Bio-pharmaceutical Co., Ltd. from 2007 to 2008 571
Figure 274 Cost structural drawing of Jinyu Baoling Bio-pharmaceutical Co., Ltd for the Year 2007-2008 572
Figure 275 Statistics of costs and expenses of Jinyu Baoling Bio-pharmaceutical Co., Ltd. from 2007 to 2008 572
Figure 276 Balance sheet of Guangdong Tengjun Animal Pharmaceutical Co., Ltd. from 2007 to 2008 574
Figure 277 Solvency of Guangdong Tengjun Animal Pharmaceutical Co., Ltd. from 2007 to 2008 575
Figure 278 Sales and profits statement of Guangdong Tengjun Animal Pharmaceutical Co., Ltd. from 2007 to 2008 575
Figure 279 Profitability of Guangdong Tengjun Animal Pharmaceutical Co., Ltd. from 2007 to 2008 575
Figure 280 Cost structural drawing of Guangdong Tengjun Animal Pharmaceutical Co., Ltd for the Year 2007-2008 575
Figure 281 Statistics of costs and expenses of Guangdong Tengjun Animal Pharmaceutical Co., Ltd. from 2007 to 2008 576
Table 282 Sales revenue forecast of veterinary drug industry in China from 2009 to 2013 589
Figure 283 Forcast of sales revenue growth trend of China’s veterinary drug industry from 2004 to 2013 590